Published in Curr Opin Hematol on January 01, 2010
Macrophages in injured skeletal muscle: a perpetuum mobile causing and limiting fibrosis, prompting or restricting resolution and regeneration. Front Immunol (2011) 1.08
Bench-to-bedside review: Platelets and active immune functions - new clues for immunopathology? Crit Care (2013) 1.02
An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes. PLoS One (2012) 0.99
Are Platelets Cells? And if Yes, are They Immune Cells? Front Immunol (2015) 0.92
Platelet CD40L at the interface of adaptive immunity. Thromb Res (2010) 0.90
Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum. Clin Exp Immunol (2014) 0.86
Neutrophils: game changers in glomerulonephritis? Trends Mol Med (2010) 0.86
Effects of ulinastatin on postoperative blood loss and hemostasis in atrioventricular valve surgery with cardiopulmonary bypass. Korean J Thorac Cardiovasc Surg (2013) 0.79
Mechanisms of xenogeneic baboon platelet aggregation and phagocytosis by porcine liver sinusoidal endothelial cells. PLoS One (2012) 0.78
Platelet Interaction with Innate Immune Cells. Transfus Med Hemother (2016) 0.78
Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic Diseases. Front Immunol (2016) 0.77
Neutrophil Phagocytosis of Platelets in the Early Phase of 2,4,6-trinitro-1-chlorobenzene (TNCB)-induced Dermatitis in Mice. Acta Histochem Cytochem (2014) 0.77
The role of platelets in the pathogenesis of systemic sclerosis. Front Immunol (2012) 0.76
Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol (2005) 3.05
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med (2008) 2.97
HMGB1: guiding immunity from within. Trends Immunol (2005) 2.42
Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur J Immunol (2005) 1.63
The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol (2006) 1.53
Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J Leukoc Biol (2009) 1.51
Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica (2010) 1.36
Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol (2009) 1.33
Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol (2008) 1.32
Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood (2011) 1.31
Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program. Blood (2009) 1.29
Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction. J Immunol (2011) 1.28
Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol (2008) 1.24
HMGB1: a two-headed signal regulating tumor progression and immunity. Curr Opin Immunol (2008) 1.21
Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function. PLoS One (2009) 1.21
Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J Leukoc Biol (2009) 1.21
The immune system and the repair of skeletal muscle. Pharmacol Res (2008) 1.20
Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes (2013) 1.17
Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med (2004) 1.15
Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum (2004) 1.13
Macrophages in injured skeletal muscle: a perpetuum mobile causing and limiting fibrosis, prompting or restricting resolution and regeneration. Front Immunol (2011) 1.08
Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J Immunol (2003) 1.08
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford) (2011) 1.06
Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia. Arthritis Rheum (2012) 1.04
High-mobility group box 1 release and redox regulation accompany regeneration and remodeling of skeletal muscle. Antioxid Redox Signal (2011) 1.03
High-mobility group box 1 (HMGB1) as a master regulator of innate immunity. Cell Tissue Res (2010) 1.02
The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J Leukoc Biol (2006) 1.01
Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage. J Immunol (2013) 1.01
Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3',5'-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells. J Immunol (2004) 0.99
An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes. PLoS One (2012) 0.99
Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma. Cancer Res (2007) 0.98
Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity (2012) 0.98
The mitochondrion--a Trojan horse that kicks off inflammation? N Engl J Med (2010) 0.98
Regulation of dendritic- and T-cell fate by injury-associated endogenous signals. Crit Rev Immunol (2009) 0.97
Endometriosis, a disease of the macrophage. Front Immunol (2013) 0.97
Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis. Antioxid Redox Signal (2014) 0.96
European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis (2012) 0.95
Redox remodeling: a candidate regulator of HMGB1 function in injured skeletal muscle. Ann N Y Acad Sci (2010) 0.95
Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis. Arthritis Res Ther (2014) 0.94
Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease. Am J Pathol (2011) 0.93
The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages. Arthritis Rheum (2004) 0.93
Magnetic resonance imaging at 7T reveals common events in age-related sarcopenia and in the homeostatic response to muscle sterile injury. PLoS One (2013) 0.92
Conversation galante: how the immune and the neuroendocrine systems talk to each other. Autoimmun Rev (2007) 0.91
Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-alpha-elicited endothelial activation. J Leukoc Biol (2008) 0.90
Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretome. Platelets (2008) 0.87
Pregnancy outcomes in patients with systemic autoimmunity. Autoimmunity (2011) 0.87
Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis. Ann N Y Acad Sci (2006) 0.87
Platelet-leukocyte deregulated interactions foster sterile inflammation and tissue damage in immune-mediated vessel diseases. Thromb Res (2012) 0.87
Leukocyte and platelet activation in patients with giant cell arteritis and polymyalgia rheumatica: a clue to thromboembolic risks? Autoimmunity (2009) 0.86
Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia. Blood (2011) 0.86
Human recombinant heat shock protein 70 affects the maturation pathways of dendritic cells in vitro and has an in vivo adjuvant activity. J Leukoc Biol (2008) 0.85
TNF-alpha coupled to membrane of apoptotic cells favors the cross-priming to melanoma antigens. J Immunol (2004) 0.85
Transplanted mesoangioblasts require macrophage IL-10 for survival in a mouse model of muscle injury. J Immunol (2012) 0.85
Fat deposition and accumulation in the damaged and inflamed skeletal muscle: cellular and molecular players. Cell Mol Life Sci (2015) 0.85
Anti-inflammatory action of apoptotic cells in patients with acute coronary syndromes. Atherosclerosis (2009) 0.84
Elevation of plasma levels of the long pentraxin 3 precedes preeclampsia in pregnant patients with type 1 diabetes. Autoimmunity (2009) 0.84
Synergism of nitric oxide and maturation signals on human dendritic cells occurs through a cyclic GMP-dependent pathway. J Leukoc Biol (2003) 0.84
Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using (18)F-FDG PET. J Nucl Med (2011) 0.83
5-Fluorouracil causes leukocytes attraction in the peritoneal cavity by activating autophagy and HMGB1 release in colon carcinoma cells. Int J Cancer (2014) 0.82
Macrophages in inflammation and its resolution. Front Immunol (2012) 0.81
Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells. J Immunother (2008) 0.81
Nitric oxide confers therapeutic activity to dendritic cells in a mouse model of melanoma. Cancer Res (2004) 0.80
Required role of apoptotic myogenic precursors and toll-like receptor stimulation for the establishment of autoimmune myositis in experimental murine models. Arthritis Rheumatol (2015) 0.80
Nitric oxide: emerging concepts about its use in cell-based therapies. Expert Opin Investig Drugs (2007) 0.80
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. Arthritis Rheum (2011) 0.80
Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort. Thromb Haemost (2009) 0.79
Melanoma cells interfere with the interaction of dendritic cells with NK/LAK cells. Int J Cancer (2006) 0.79
Dendritic cells and the shadow line between autoimmunity and disease. Arthritis Rheum (2005) 0.78
Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy. Clin Chem Lab Med (2010) 0.78
Characterisation of functional biotinylated TNF-alpha targeted to the membrane of apoptotic melanoma cells. J Immunol Methods (2003) 0.78
HMGB1: An immmune odyssey. Discov Med (2005) 0.77
Efficacy and toxicity of treatments for nephritis in a series of consecutive lupus patients. Autoimmunity (2013) 0.77
The role of platelets in the pathogenesis of systemic sclerosis. Front Immunol (2012) 0.76
Innate responses to Aspergillus: role of C1q and pentraxin 3 in nasal polyposis. Am J Rhinol (2007) 0.76
Requirement for dendritic cells in the establishment of anti-phospholipid antibodies. Autoimmunity (2007) 0.76
Neutrophils and sepsis. Lancet (2006) 0.75
Standardization in flow cytometry: correct sample handling as a priority. Nat Rev Immunol (2012) 0.75
Platelet clearance by circulating leukocytes: a rare event or a determinant of the "immune continuum"? Platelets (2013) 0.75
Formation of mixed platelet-PMN leukocyte aggregates in the platelet function analyzer (PFA-100) device. Thromb Haemost (2007) 0.75